Patient Feedback Pioneers: Chronic Fatigue Advocates Prepare for First PDUFA V Meeting

FDA has selected CFS/ME as the first topic for the PDUFA V patient-centered drug development initiative. The lessons learned from this session will inform future work on patient engagement in drug development both for FDA—and for patient advocates.

More from Approval Standards

More from Pathways & Standards